(Q43918476)

28 November 2017

title

Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse (English)

1 reference

28 November 2017

1 reference

2

1 reference

28 November 2017

Catherine Anne Abbott

3

1 reference

28 November 2017

Min Wang

1

1 reference

28 November 2017

Rene Jaggi

4

1 reference

28 November 2017

Didier Marguet

5

1 reference

28 November 2017

Ronald G Dickinson

6

1 reference

28 November 2017

language of work or name

1 reference

1 January 2002

1 reference

Journal of Gastroenterology and Hepatology

28 November 2017

published in

1 reference

28 November 2017

volume

17

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

66-71

1 reference

Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

CD26, let it cut or cut it down.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Dipeptidyl peptidase IV is a target for covalent adduct formation with the acyl glucuronide metabolite of the anti-inflammatory drug zomepirac

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Irreversible binding of zomepirac to plasma protein in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02662.X

10.1046/J.1440-1746.2002.02662.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference